GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kabra Drugs Ltd (BOM:524322) » Definitions » Valuation Rank

Kabra Drugs (BOM:524322) Valuation Rank


View and export this data going back to 1993. Start your Free Trial

What is Kabra Drugs Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.


Kabra Drugs Valuation Rank Related Terms

Thank you for viewing the detailed overview of Kabra Drugs's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Kabra Drugs Business Description

Traded in Other Exchanges
N/A
Address
No. 3, Swaminathan Street, 2nd Floor, West Mambalam, Chennai, TN, IND, 600 033
Kabra Drugs Ltd is an India-based drug manufacturing company. It is engaged in the business of Permaculture manufacturing and trading in pharma related products. Geographically, all the company operations are carried out in India. The company's drug manufacturing plant is located in Madhya Pradesh, India. Its products include Cardiovascular Drugs, Anti-Infective Drugs, Oncology Drugs, Gastroenterologic Drugs, Hormonal Drugs, etc.